Specifically, activated microglia use CSF1R signalling to drive demyelination, especially in progressive MS [161,171]; conversely, CSF1R inhibition has been shown to reduce neuroinflammation and microglial activation in the EAE model [169]. This evidence concerns the gene CSF1R and myeloid sarcoma.